Stefan Sleijfer

机构：Erasmus MC, Erasmus MC Cancer Institute, Erasmus University Rotterdam · ORCID：0000-0002-0446-9039

发表论文 663 篇 · 总被引 29014 次 · h-index 81

代表论文

• Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis (2025 · Clinical Cancer Research · 被引 16)
• Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker study (2025 · EClinicalMedicine · 被引 11)
• LBA61 Early discontinuation of anti-PD-1 therapy upon achieving a complete or partial response in patients with metastatic melanoma: The multicentre prospective Safe Stop Trial (2025 · Annals of Oncology · 被引 2)
• Clinical validity of repeated circulating tumor cell enumeration as an early treatment monitoring tool for metastatic breast cancer in the PREDICT global pooled analysis. (2026 · UNC Libraries)
• Modernizing evidence generation for clinical artificial intelligence: the case for adaptive platform trials (2026 · npj Digital Medicine)
• Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer (2026 · Diagnostics)